Familial Gullo’s Syndrome: a clinical case report

Mauro Turrin, Lucia Fornasiero

DOI: https://doi.org/10.7175/cmi.v15i1.1493

Abstract

This case report describes a male patient born in 1953 presenting an occasional increase in serum amylase and lipase forty years ago. The monitoring of enzymes was accompanied by radiological investigations, which did not reveal pancreatic pathology. In his family, including 10 siblings, half were carriers of this isolated anomaly; multiple cysts in pancreas, kidneys, and liver were present in some family members, in addition to a pancreatic neoplasia in a sister who did not carry the enzymatic abnormality. Our patient developed colon adenocarcinoma at the age of 67.

Here we examine the characteristics of non-pathological chronic pancreatic hyperenzymemia defined as such by the main Italian pioneer Professor Gullo.

Keywords

Hyperamylasemia; Hyperlipasemia; Familial Pancreatic Hyperenzimemia; Gullo’s Syndrome; Magnetic Resonance Cholangiopancreatography Imaging

Full Text

HTML PDF

References

  • Gullo L, Lucrezio L, Migliori M, et al. Benign pancreatic hyperenzymemia or Gullo’s syndrome. Adv Med Sci 2008; 53: 1-5; https://doi.org/10.2478/v10039-008-0027-7
  • Gullo L, Lucrezio L, Calculli L, et al. Magnetic resonance cholangiopancreatography in asymptomatic pancreatic hyperenzymemia. Pancreas 2009; 38: 396-400; https://doi.org/10.1097/MPA.0b013e31819d73b3
  • Galassi E, Birtolo C, Migliori M, et al. A 5-year experience of benign pancreatic hyperenzymemia. Pancreas 2014; 43: 874-8; https:/doi.org/10.1097/MPA.0000000000000138
  • Masuko K, Morishita T. Chronic Asymptomatic Hyperenzymemia of the Pancreas Suggestive of the Presence of Undiagnosed Sjögren Syndrome. Pancreas 2020; 49: e85-e86; https://doi.org/10.1097/MPA.0000000000001645
  • Iida T, Wagatsuma K, Hirayama D, et al. The Etiology of Pancreatic Manifestations in Patients with Inflammatory Bowel Disease. J Clin Med 2019; 8: 916; https://doi.org/10.3390/jcm8070916
  • Frulloni L, Patrizi F, Bernardoni L, et al. Pancreatic hyperenzymemia: clinical significance and diagnostic approach. JOP 2005; 6: 536-51
  • Turrin M. Rare Causes of Acute Pancreatitis: Drugs, Eosinophilia, and Autoimmunity. OBM Hepatology and Gastroenterology 2019; 3: 20; https://doi.org/10.21926/obm.hg.1903034
  • Pezzilli R. Familial pancreatic hyperenzymemia. Pancreatic Dis Ther 2013; S1: e001; https://doi.org/10.417272165-7092.s1-e001
  • Di Leo M, Petrone MC, Zuppardo RA, et al. Pancreatic morpho-functional imaging as diagnostic approach for chronic asymptomatic pancreatic hyperenzymemia. Dig Liver Dis 2016; 48: 1330-5; https://doi.org/10.1016/j.dld.2016.08.109
  • Amodio A, Manfredi R, Katsotourchi AM, et al. Prospective evaluation of subjects with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol 2012; 107: 1089-95; https://doi.org/10.1038/ajg.2012.125
  • Gonoi W, Hayashi TY, Hayashi N, et al. Association between chronic asymptomatic pancreatic hyperenzymemia and pancreatic ductal anomalies: a magnetic resonance cholangiopancreato graphy study. Abdom Radiol (NY) 2019; 44: 2494-500; https://doi.org/10.1007/s00261-019-02004-4
  • Pezzilli R, Morselli-Labate AM, Casadei R, et al. Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study. Scand J Gastroenterol 2009; 44: 888-93; https://doi.org/10.1080/00365520902839683
  • Testoni PA, Mariani A, Curioni S, et al. Pancreatic ductal abnormalities documented by secretin-enhanced MRCP in asymptomatic subjects with chronic pancreatic hyperenzymemia. Am J Gastroenterol 2009; 104: 1780-6; https://doi.org/10.1038/ajg.2009.158
  • Mortelè KJ, Wiesner W, Zou H, et al. Asymptomatic nonspecific serum hyperamylasemia and hyperlipasemia: spectrum of MRCP findings and clinical implications. Abdomen Imaging 2004; 29: 109-14; https://doi.org/10.1007/s00261-003-0072-4
  • Amodio A, De Marchi G, Granato A, et al. Chronic asymptomatic pancreatic hyperenzymemia: a long-term follow-up. Pancreas 2019; 48: 544-7; https://doi.org/10.1097/MPA.0000000000001272
  • Antonini F, Belfiori V, Pagano N, et al. Endoscopic ultrasonography may select subjects who require a stricter follow-up. Pancreas 2017; 46: 524-7; https://doi.org/10.1097/MPA.0000000000000796
  • Sitaraman LM, Sachdev AH, Gonda TA, et al. The utility of endoscopic ultrasound in patients with isolated elevations in serum amylase and/or lipase. Clin Endosc 2019; 52: 175-81; https://doi.org/10.5946/ce.2018.110
  • Vanella G, Arcidiacono PG, Capurso G. Chronic asymptomatic pancreatic hyperenzymemia (CAPH): meta-analysis of pancreatic finding at second-level imaging. Pancreatology 2019; 19: 237-44; https://doi.org/10.1016/ j.pan.2019.01.022
  • Gullo L. Benign pancreatic hyperenzymemia. Dig Liver Dis 2007; 39: 698-702; https://doi.org/10.1016/j.dld.2007.03.005
  • Catanzaro R, Italia A. Iperenzimemia pancreatica: recenti acquisizioni in tema di approccio clinico-diagnostico, con particolare attenzione alla sindrome di Gullo [Pancreatic hyperenzymemia: new advances in the field of clinical-diagnostic approach, with particular attention about Gullo’s syndrome]. Minerva Med 2012; 103: 393-412
  • Zerboni G, Signoretti M, Crippa S, et al. Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology 2019; 19: 2-9; https://doi.org/10.1016/j.pan.2018.11.014. Epub 2018 Nov 28
  • Zhu S, Wang WT, Shang XS, et al. Difference analysis in prevalence of incidental pancreatic cystic lesions between computed tomography and magnetic resonance imaging. BMC Med Imaging 2019; 19: 43; https://doi.org/10.1186/s12880-019-0341-5
  • Khoury T, Kadah A, Mari A, et al. The utility of endoscopic ultrasound fine needle aspiration in pancreatic cystic lesions diagnosis. Diagnostics 2020; 10: 507; https://doi.org/10.3390/diagnostics10080507
  • Ribaldone DG, Bruno M, Gaia S, et al. Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration. Dig Liver Dis 2020; 52: 1026-32; https://doi.org/10.1016/j.dld.2020.06.038. Epub 2020 Jul 13
  • Tacelli M, Celsa C, Magro B, et al. Diagnostic performance of endoscopic ultrasound through-the-needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta-analysis. Dig Endosc 2020; 32: 1018-30; https://doi.org/10.1111/den.13626
  • Pezzilli R, Morselli-Labate AM, Calculli L, et al. Long-Standing Pancreatic Hyperenzymemia: Is It a Nonpathological Condition? Case Rep Gastroenterol 2009; 3: 111-5; https://doi.org/10.1159/000213479
  • Birtolo C, Migliori M, Drewes AM, et al. Benign pancreatic hyperenzymemia: lights on a clinical challenge. Pancreas 2017; 46: 5-7; doi: 10.1097/MPA.0000000000000723
  • Gullo L, Mantovani V, Manca M, et al. Mutations of the CFTR gene in idiopathic pancreatic hyperenzymemia. Pancreas 2005; 31: 350-2
  • Gullo L, Laghi L, Migliori M, et al. SPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemia. Pancreas 2008; 37: 31-5; https://doi.org/10.1097/MPA.0b013e31816172b7
  • Valente R, Antonelli M, Piciucchi M, et al. Celiac disease and CFTR mutations in patients with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol 2013; 108: 618; https://doi.org/10.1038/ajg.2013.13
  • Cavallo P, Carpinelli L, Zingone F, et al. Prevalence and correlates of benign pancreatic hyperenzymemia in a large general population sample: the Damocles sword perception. Pancreatology 2019; 19: 409-13; https://doi.org/10.1016/j.pan.2019.03.003
  • Murabito LM, Famà F, Gioffrè-Florio MA. Benign pancreatic hyperenzimemia or Gullo’s syndrome: incidence in patients admitted to an emergency department. Gazzetta Medica Italiana Archivio per le Scienze Mediche 2016; 175: 40-7
  • Mehta P, Reddivari AKR. A Case Report of Benign Pancreatic Hyperenzymemia (Gullo’s Syndrome). Cureus 2020; 12: e8143; https://doi.org/10.7759/cureus.8143
  • Kumar P, Ghosh A, Tandon V, et al. Gullo’s Syndrome: A Case Report. J Clin Diagn Res 2016; 10: OD21-OD22; https://doi.org/10.7860/JCDR/2016/17038.7285. Epub 2016 Feb 1
  • Yang BL, Wu WC, Su CW, et al. Healthy Chinese with benign pancreatic hyperenzymemia. J Chin Med Assoc 2015; 78: 623-6; https://doi.org/10.1016/j.jcma.2015.05.011. Epub 2015 Aug 10
  • Wiederkehr JC, Wiederkehr BA, Wiederkehr HA, et al. Nonspecific hyperamylasemia: a case report. JOP 2013; 14: 74-6; https://doi.org/10.6092/1590-8577/1216
  • Schnedl WJ, Enko D, Mangge H, et al. Benign pancreatic hyperenzymemia (Gullo syndrome), histamine intolerance, and carbohydrate malabsorption. Proc (Bayl Univ Med Cent) 2017; 30: 177-8; https://doi.org/10.1080/08998280.2017.11929574
  • Rycyk A, Furtak P, Mądro A, et al. Gullo’s Syndrome: case report. J Pre-Clin Clin Res 2020; 14: 117-9; https://doi.org/10.26444/jpccr/127792
  • Gubergrits NB, Gubska O, Klochkov AY, et al. Clinical Case Report of Familial Benign Pancreatic Hyperenzymemia. Pancreas 2018; 47: e35-e36; https://doi.org/10.1097/MPA.0000000000001078
  • Bachmeier CAE, Morton A. Man with epigastric pain and persistently elevated serum lipase. BMJ Case Reports CP 2019; 12: e229208
  • Rosell-Camps A, Martínez-Cepas P, Riera-Llodrá JM, et al. Benign Pancreatic Hyperenzymemia, Also Known as Gullo›s Syndrome. Lab Med 2020; 51: 423-5; https://doi.org/10.1093/labmed/lmz077
  • de Alba Iriarte B, López N, Rubio A, et al. Gullo´s Syndrome (Benign Pancreatic Hyperenzymemia): Report of the First Two Cases in Basque Country. J Case Rep Stud 2019; 7: 40
  • Pérez M, Colina N, Daoud G, et al. Hiperenzimemia pancreática benigna familiar: Sindrome de Gullo. A proposito de un caso [Familial benign pancreatic hyperenzimemia: a case report] Revista Gen 2016; 70: 23-7
  • Ainahi A, Ziane A, Wakrim L, et al. An Unusual Case of Gullo’s Syndrome Concomitant with Serious Endometriosis Disease in a Postmenopausal Woman. Case Rep Med 2018; 2018: 6310245; https://doi.org/10.1155/2018/6310245
  • Lankisch PG. Erhöhte Pankreasenzyme ohne erkennbare Pankreaserkrankung [Elevated pancreatic enzymes without evident pancreatic disease]. Dtsch Med Wochenschr 2009; 134: 2232-5; https://doi.org/ 10.1055/s-0029-1241932
  • Catanzaro R, Sciuto M, Adamo G, et al. Benign pancreatic hyperenzymemia-Gullo’s syndrome: focus on this clinical challenge. A monocentric retrospective study. Minerva Med 2019; 110: 490-8; https://doi.org/10.23736/S0026-4806.19.06046-4
  • Gullo L, Migliori M. Benign pancreatic hyperenzymemia in children. Eur J Pediatr 2007; 166: 125-9; https://doi.org/10.1007/s00431-006-0264-3
  • Lionetti E, Francavilla R, Leonardi S, et al. Two rare cases of benign hyperlipasemia in children. World J Clin Cases 2014; 2: 16-9; https://doi.org/10.12998/wjcc.v2.i1.16
  • Parisi E, Carboni E, Mazza GD, et al. Benign pancreatic hyperenzymemia: Gullo’s syndrome. Dig Liver Dis 2017; 49: e252; https://doi.org/101016/j.dld.2017.09.028;
  • Gullo L. Familial pancreatic hyperenzymemia. Pancreas 2000; 20: 158-60; https://doi.org/10.1097/00006676-200003000-00008

Statistics

Abstract: 65 views
HTML: 23 views
PDF: 43 views

Refbacks

  • There are currently no refbacks.




© SEEd srl